Retinal detachment still a common problem

Article

Retinal detachment is still the most common serious complication of macular surgery.

Retinal detachment is still the most common serious complication of macular surgery, according to a report published in the October issue of the British Journal of Ophthalmology.

Alexandre Guillaubey and colleagues from University Hospital Dijon and University Hospital Nancy, France conducted a retrospective, non-randomized study of 634 macular surgery procedures (idiopathic macular hole surgery [IMH] n=272; epiretinal membrane surgery [ERM] n=362).

No retinal detachment was seen in patients presenting with an intraoperative or preoperative successfully treated retinal break. There was a higher rate of retinal detachment occurring after IMH surgery than after ERM surgery (6.6% versus 2.5%, p=0.02) and furthermore, the rate of retinal detachment was higher in patients presenting with stage 2 and 3 IMH than with stage 4 IMH.

The results demonstrate that retinal detachment is still a common complication following macular surgery and that surgical detachment of the posterior vitreous face and associated peripheral retina anomaly appear to increase the rate of this complication. The authors of this study suggest that careful examination of the peripheral retina is essential in helping to prevent this complication.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.